These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1258931)

  • 1. An investigation of the effects of the intrauterine contraceptive device based on a longitudinal study of a self-selected sample of Barbadian women.
    Barron BA; Weinstein H; Richart RM
    Am J Obstet Gynecol; 1976 Apr; 124(7):723-9. PubMed ID: 1258931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current use of an intrauterine device and risk of tubal pregnancy.
    Rossing MA; Daling JR; Voigt LF; Stergachis AS; Weiss NS
    Epidemiology; 1993 May; 4(3):252-8. PubMed ID: 8512989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pregnancies with intra-uterine devices in-situ (author's transl)].
    Obolensky W; Bucheli J
    Geburtshilfe Frauenheilkd; 1975 Aug; 35(8):632-9. PubMed ID: 1175906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of pregnancy in the presence of intrauterine device.
    Koetsawang S; Rachawat D; Piya-Anant M
    Acta Obstet Gynecol Scand; 1977; 56(5):479-82. PubMed ID: 602718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
    Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
    Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancies with intra-uterine contraceptive device in situ.
    Nahamanovici C; Eymery JP; Salvat J; Robert Y; Racinet C
    Contracept Fertil Sex (Paris); 1979 May; 7(5):341-7. PubMed ID: 12335901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine device use and risk of tubal pregnancy: an Indonesian case-control study.
    Basuki B; Rossing MA; Daling JR
    Int J Epidemiol; 1994 Oct; 23(5):1000-5. PubMed ID: 7860150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IUD in first-trimester abortion: immediate intrauterine contraceptive devices insertion vs delayed insertion following the next menstruation bleeding.
    Tsikouras P; Vrachnis N; Grapsa A; Tsagias N; Pinidis P; Liberis A; Ammari A; Grapsas X; Galazios G; Liberis V
    Arch Gynecol Obstet; 2014 Jul; 290(1):99-105. PubMed ID: 24573506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydial serologic characteristics among intrauterine contraceptive device users: does copper inhibit chlamydial infection in the female genital tract?
    Mehanna MT; Rizk MA; Ramadan M; Schachter J
    Am J Obstet Gynecol; 1994 Sep; 171(3):691-3. PubMed ID: 8092216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.
    Cohen R; Sheeder J; Arango N; Teal SB; Tocce K
    Contraception; 2016 Feb; 93(2):178-83. PubMed ID: 26475368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Uterine and extrauterine pregnancy after insertion of contraceptive intrauterine device].
    Carayon A; Honorat M
    Bull Soc Med Afr Noire Lang Fr; 1968; 13(3):707-9. PubMed ID: 5729018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intrauterine contraception in nulliparous women].
    Prilepskaia VN; Mezhevitinova EA
    Akush Ginekol (Mosk); 1991 Apr; (4):5-8. PubMed ID: 1862876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective New Zealand study of fertility after removal of copper intrauterine contraceptive devices for conception and because of complications: a four-year study.
    Wilson JC
    Am J Obstet Gynecol; 1989 Feb; 160(2):391-6. PubMed ID: 2916624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of intrauterine contraceptives].
    Parshina LA; Konishcheva OE
    Akush Ginekol (Mosk); 1977 Dec; (12):39-40. PubMed ID: 605979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting intrauterine contraceptive device performance. I. Endometrial cavity length.
    Hasson HM; Berger GS; Edelman DA
    Am J Obstet Gynecol; 1976 Dec; 126(8):973-81. PubMed ID: 998687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Copper T 220C: a new long-acting copper intrauterine contraceptive device.
    Cooper DL; Millen AK; Mishell DR
    Am J Obstet Gynecol; 1976 Jan; 124(2):121-4. PubMed ID: 1247047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management and outcome of pregnancies associated with the Copper T intrauterine contraceptive device.
    Tatum HJ; Schmidt FH; Jain AK
    Am J Obstet Gynecol; 1976 Dec; 126(7):869-79. PubMed ID: 1033668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinued use of intrauterine contraceptive device and pregnancy loss.
    Levin AA; O'Shea M; Schoenbaum SC; Monson RR; Stubblefield PG; Ryan KJ
    Am J Obstet Gynecol; 1984 Aug; 149(7):768-71. PubMed ID: 6465229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.